Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 13219
TargetCytochrome P450 2C9(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767581(2-cyclopropyl-N-(((S)-7-ethyl-7-hydroxy-8,11-dioxo...)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767581(2-cyclopropyl-N-(((S)-7-ethyl-7-hydroxy-8,11-dioxo...)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767581(2-cyclopropyl-N-(((S)-7-ethyl-7-hydroxy-8,11-dioxo...)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767584(2-cyclopropyl-N-(((S)-7-ethyl-7-hydroxy-8,11-dioxo...)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767583(US20250270227, Compound 37-P1)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767583(US20250270227, Compound 37-P1)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767584(2-cyclopropyl-N-(((S)-7-ethyl-7-hydroxy-8,11-dioxo...)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767584(2-cyclopropyl-N-(((S)-7-ethyl-7-hydroxy-8,11-dioxo...)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767582(US20250270227, Compound 14-P2)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767582(US20250270227, Compound 14-P2)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767583(US20250270227, Compound 37-P1)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Simcere Zaiming Pharmaceutical Co.

US Patent
LigandPNGBDBM767582(US20250270227, Compound 14-P2)
Affinity DataIC50: 5.00E+4nMAssay Description:1. Preparation of 100 mM phosphate buffered saline (PBS): 7.098 g of Na2HPO4 was weighed, 500 mL of pure water was added and subjected to ultrasonic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/9/2025
Entry Details
US Patent